Zinbryta: A Lifeline for Biogen Inc and AbbVie Inc Survival - Business Finance News

Business Finance News

Zinbryta: A Lifeline for Biogen Inc and AbbVie Inc Survival Business Finance News Both, Biogen Inc. (NASDAQ:BIIB) and AbbVie are in a dire need for a molecule that aid in the company's future revenue growth. Multiple sclerosis franchises is the pillar of Biogen growth. The company extracts approximately 80% of its revenue from it ... Nortek and Harmony Gold rise; Netflix and United skidWashington Post Stocks turn higher, but investors remain cautiousThe Boston Globe Biogen, AbbVie: How Significant is the New MS Drug ZinbrytaBidness ETC Pharmaceutical Processing -Seeking Alpha -Yahoo Finance -Labiotech.eu (blog) all 20 news articles »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNHO1BZVhwluY7wbt07qgwe3NTTulQ&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779149878677&ei=711-V_icE9fC3gHb1raAAg&url=http://www.businessfinancenews.com/29520-zinbryta-a-lifeline-for-biogen-inc-and-abbvie-inc-survival/
via IFTTT